1. Graversen M, Lundell L, Fristrup C, Pfeiffer P, Mortensen MB. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure. Pleura Peritoneum. 2018;3(4):20180128. Published 2018 Nov 27. doi:10.1515/pp-2018-0128

2. Leebmann H, Piso P. PIPAC und HIPEC – konkurrierende oder ergänzende Therapieverfahren bei peritonealen Metastasen [PIPAC and HIPEC-competing or supplementary therapeutic procedures for peritoneal metastases]. Chirurg. 2018;89(9):693–698. doi:10.1007/s00104-018-0666-6

3. Bakrin N, Tempfer C, Scambia G, et al. PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Pleura Peritoneum. 2018;3(3):20180114. Published 2018 Sep 25. doi:10.1515/pp-2018-0114

4. Graversen M, Detlefsen S, Asmussen J, et al. Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC-OPC2. Pleura Peritoneum. 2018;3(2):20180108. Published 2018 Jun 9. doi:10.1515/pp-2018-0108

5. Gockel I, Jansen-Winkeln B, Haase L, et al. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Cancer Patients with Peritoneal Metastasis (PM): Results of a Single-Center Experience and Register Study. J Gastric Cancer. 2018;18(4):379–391. doi:10.5230/jgc.2018.18.e37

6. Eveno C, Jouvin I, Pocard M. PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study. Pleura Peritoneum. 2018;3(2):20180116. Published 2018 Jun 21. doi:10.1515/pp-2018-0116

7. Kurtz F, Struller F, Horvath P, et al. Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study. Gastroenterol Res Pract. 2018;2018:2743985. Published 2018 Oct 24. doi:10.1155/2018/2743985

8. Alyami M, Gagniere J, Sgarbura O, et al. Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis. Eur J Surg Oncol. 2017;43(11):2178–2183. doi:10.1016/j.ejso.2017.09.010

9. Horvath P, Beckert S, Struller F, Königsrainer A, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer. Clin Exp Metastasis. 2018;35(7):635–640. doi:10.1007/s10585-018-9925-7

10. Di Giorgio A, Abatini C, Attalla El Halabieh M, et al. From palliation to cure: PIPAC for peritoneal malignancies. Minerva Med. 2019;110(4):385–398. doi:10.23736/S0026-4806.19.06081-6

11. Nowacki M, Alyami M, Villeneuve L, et al. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. Eur J Surg Oncol. 2018;44(7):991–996. doi:10.1016/j.ejso.2018.02.014

12. Alyami M, Mercier F, Siebert M, et al. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [published online ahead of print, 2019 Jun 21]. Eur J Surg Oncol. 2019;S0748-7983(19)30522-0. doi:10.1016/j.ejso.2019.06.028

13. Graversen M, Detlefsen S, Fristrup C, Pfeiffer P, Mortensen MB. Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients - study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study. Pleura Peritoneum. 2018;3(2):20180107. Published 2018 Jun 12. doi:10.1515/pp-2018-0107

14. Graversen M, Detlefsen S, Pfeiffer P, Lundell L, Mortensen MB. Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey. Clin Exp Metastasis. 2018;35(3):103–108. doi:10.1007/s10585-018-9895-9

15. Tempfer CB, Hilal Z, Dogan A, Petersen M, Rezniczek GA. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis. Eur J Surg Oncol. 2018;44(7):1112–1117. doi:10.1016/j.ejso.2018.04.020

16. Sgarbura O, Hübner M, Alyami M, et al. Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study. Eur J Surg Oncol. 2019;45(12):2386–2391. doi:10.1016/j.ejso.2019.05.007

17. Somashekhar SP, Ashwin KR, Rauthan CA, Rohit KC. Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy. Pleura Peritoneum. 2018;3(3):20180110. Published 2018 Sep 26. doi:10.1515/pp-2018-0110

18. Graversen M, Detlefsen S, Bjerregaard JK, Fristrup CW, Pfeiffer P, Mortensen MB. Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis. Ther Adv Med Oncol. 2018;10:1758835918777036. Published 2018 Jun 1. doi:10.1177/1758835918777036

19. Eveno C, Haidara A, Ali I, Pimpie C, Mirshahi M, Pocard M. Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy. Pleura Peritoneum. 2017;2(2):103–109. doi:10.1515/pp-2017-0015

20. Kim G, Tan HL, Chen E, et al. Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis. Pleura Peritoneum. 2018;3(3):20180118. Published 2018 Aug 29. doi:10.1515/pp-2018-0118

21. Alyami M, Hübner M, Grass F, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20(7):e368–e377. doi:10.1016/S1470-2045(19)30318-3

22. Tan H, Kim G, Jang C, et al. PIPAC paclitaxel: A systematic and peritoneal tissue pharmacokinetic study in swine. Ann Oncol. 2019;30 Suppl 4:iv73. doi:10.1093/annonc/mdz155.268

23. Robella M, Vaira M, De Simone M. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis. World J Surg Oncol. 2016;14:128. Published 2016 Apr 29. doi:10.1186/s12957-016-0892-7

24. Vaira M, Robella M, Borsano A, De Simone M. Single-port access for Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): technique, feasibility and safety. Pleura Peritoneum. 2016;1(4):217–222. doi:10.1515/pp-2016-0021

25. Garg PK, Jara M, Alberto M, Rau B. The role of Pressurized IntraPeritoneal Aerosol Chemotherapy in the management of gastric cancer: A systematic review. Pleura Peritoneum. 2019;4(1):20180127. Published 2019 Mar 5. doi:10.1515/pp-2018-0127

26. Girshally R, Demtröder C, Albayrak N, Zieren J, Tempfer C, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2016;14(1):253. Published 2016 Sep 27. doi:10.1186/s12957-016-1008-0

27. Odendahl K, Solass W, Demtröder C, et al. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Eur J Surg Oncol. 2015;41(10):1379–1385. doi:10.1016/j.ejso.2015.06.001

28. Dumont F, Senellart H, Pein F, et al. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design. Pleura Peritoneum. 2018;3(3):20180120. Published 2018 Sep 15. doi:10.1515/pp-2018-0120

29. Teixeira Farinha H, Grass F, Kefleyesus A, et al. Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study. Gastroenterol Res Pract. 2017;2017:4596176. doi:10.1155/2017/4596176

30. Khosrawipour T, Khosrawipour V, Giger-Pabst U. Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma. PLoS One. 2017;12(10):e0186709. Published 2017 Oct 19. doi:10.1371/journal.pone.0186709

31. Demtröder C, Solass W, Zieren J, Strumberg D, Giger-Pabst U, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis. 2016;18(4):364–371. doi:10.1111/codi.13130

32. Hübner M, Grass F, Teixeira-Farinha H, Pache B, Mathevet P, Demartines N. Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects. Eur J Surg Oncol. 2017;43(6):1102–1109. doi:10.1016/j.ejso.2017.03.019

33. Solass W, Kerb R, Mürdter T, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21(2):553–559. doi:10.1245/s10434-013-3213-1

34. Tempfer CB. Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis. Med Hypotheses. 2015;85(4):480–484. doi:10.1016/j.mehy.2015.07.001